Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-12

Clinical Trial Update: Rapid Antidepressant Effects of Ketamine in Major Depression [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial investigating rapid antidepressant effects of ketamine in major depression completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Depression, Mood Disorders | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-10-12